rawfin.tv
BioNTech Files Form 144 for Sale of ADS and Exercised Shares
RegulationstocksAI Generated

BioNTech Files Form 144 for Sale of ADS and Exercised Shares

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

BioNTech SE has submitted a Form 144 notice, indicating an intent to sell American Depositary Shares (ADS) and exercised ordinary shares. This regulatory filing typically precedes a sale by affiliates or large shareholders.

BNTXForm 144ADSShare SaleBiotechnologyRegulatory Filing

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks